PBLA — Panbela Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Panbela Therapeutics Received A Notice Of Delisting Or Failure To Satisfy A Standard From Nasdaq
Brief: Panbela Therapeutics Received Notice Of Delisting Or Failure To Satisfy A Standard From Nasdaq
Brief: Panbela Announces 2nd Independent Safety Review Of The Aspire Registration Clinical Trial
Brief: Panbela Announces Validation Of European Patent In UK, Italy, Germany, France, And Spain For Claims Of A Novel Process For The Production Of SBP-101
Brief: Panbela Announces Issuance Of New Patent In China For Claims Of A Novel Process For The Production Of Sbp-101
Brief: Panbela Announces Issuance Of New Patent In Chile For A Novel Process To Produce Flynpovi
Panbela Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Panbela Therapeutics Inc expected to post a loss of $4.70 a share - Earnings Preview
Brief: Panbela Opens Enrollment In UK And Germany For Aspire Trial In Pancreatic Cancer
U.S. STOCKS ON THE MOVE-Bluebird bio, Panbela, Northern Trust
Panbela gains after divesting rights to pediatric cancer drug
Brief: Panbela Therapeutics To Receive Up To $9.5 Mln For Divestiture Of Assets Within Eflornithine (DFMO) Pediatric Neuroblastoma Program To Us WorldMeds
Brief: Panbela Announces Issuance Of New Patent In Australia
U.S. STOCKS ON THE MOVE-Novavax, Domino's Pizza, Fox Corp